Evidence map›Paper›PMID 34480670›Full record

ArticleAntonie van Leeuwenhoek2021

Gulosibacter hominis sp. nov.: a novel human microbiome bacterium that may cause opportunistic infections.

Peter Vandamme, Charlotte Peeters, Helena M B Seth-Smith, Lukas Graf, Margo Cnockaert, Adrian Egli, Daniel Goldenberger

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Rare Case ofInfection and drug resistance · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Peter VandammeLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, K. L. Ledeganckstraat 35, 9000, Ghent, Belgium. Peter.Vandamme@ugent.be.ORCID http://orcid.org/0000-0002-5581-7937
Charlotte PeetersLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, K. L. Ledeganckstraat 35, 9000, Ghent, Belgium.
Helena M B Seth-SmithApplied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
Lukas GrafEar, Nose and Throat Department, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Margo CnockaertLaboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, K. L. Ledeganckstraat 35, 9000, Ghent, Belgium.
Adrian EgliApplied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
Daniel GoldenbergerDivision of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. Daniel.Goldenberger@usb.ch.
Ghent University · BEUniversity Hospital of Basel · CHUniversity of Basel · CHUniversity College Ghent · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present genomic, phylogenomic, and phenotypic taxonomic data to demonstrate that three human ear isolates represent a novel species within the genus Gulosibacter. These isolates could not be identified reliably using MALDI-TOF mass spectrometry during routine diagnostic work, but partial 16S rRNA gene sequence analysis revealed that they belonged to the genus Gulosibacter. Overall genomic relatedness indices between the draft genome sequences of the three isolates and of the type strains of established Gulosibacter species confirmed that the three isolates represented a single novel Gulosibacter species. A biochemical characterisation yielded differential tests between the novel and established Gulosibacter species, which could also be differentiated using MALDI-TOF mass spectrometry. We propose to formally classify these three isolates into Gulosibacter hominis sp. nov., with 401352-2018

Indexed as

MicrobiotaOpportunistic InfectionsBacterial Typing TechniquesDNA, BacterialFatty AcidsHumansNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialFatty AcidsRNA, Ribosomal, 16SEar sampleGulosibacter hominisHuman gut microbiome reference genomeHuman microbiomePseudoclavibacterSkin microbiomeWhole genome sequence

Identifiers

PMID34480670
OpenAlexW3198508347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.